GHP Investment Advisors Inc. Has $2.21 Million Holdings in Colgate-Palmolive (NYSE:CL)

GHP Investment Advisors Inc. decreased its stake in shares of Colgate-Palmolive (NYSE:CL) by 6.3% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 21,331 shares of the company’s stock after selling 1,430 shares during the quarter. GHP Investment Advisors Inc.’s holdings in Colgate-Palmolive were worth $2,214,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of CL. Wealth Enhancement Advisory Services LLC increased its stake in Colgate-Palmolive by 16.4% in the third quarter. Wealth Enhancement Advisory Services LLC now owns 254,923 shares of the company’s stock valued at $26,464,000 after purchasing an additional 35,986 shares in the last quarter. NorthCrest Asset Manangement LLC bought a new stake in Colgate-Palmolive in the 3rd quarter valued at about $208,000. Forsta AP Fonden increased its position in Colgate-Palmolive by 6.3% in the 3rd quarter. Forsta AP Fonden now owns 246,400 shares of the company’s stock valued at $25,579,000 after buying an additional 14,600 shares in the last quarter. Allworth Financial LP raised its stake in Colgate-Palmolive by 16.2% during the 3rd quarter. Allworth Financial LP now owns 17,890 shares of the company’s stock worth $1,857,000 after buying an additional 2,500 shares during the period. Finally, Heritage Financial Services LLC bought a new position in Colgate-Palmolive in the third quarter worth approximately $212,000. Institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Colgate-Palmolive news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Sally Massey sold 15,850 shares of the business’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock valued at $4,486,063 in the last 90 days. 0.34% of the stock is currently owned by company insiders.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $95.61 on Friday. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.70 and a current ratio of 1.06. The firm has a market cap of $78.44 billion, a price-to-earnings ratio of 30.26, a P/E/G ratio of 3.54 and a beta of 0.40. The firm’s 50-day simple moving average is $103.15 and its two-hundred day simple moving average is $97.98. Colgate-Palmolive has a 52 week low of $71.46 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, October 25th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.88 by $0.03. The business had revenue of $5.03 billion for the quarter, compared to the consensus estimate of $5.01 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. As a group, equities analysts forecast that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be paid a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.09%. Colgate-Palmolive’s dividend payout ratio is 63.29%.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on CL. UBS Group boosted their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a report on Wednesday, September 4th. Jefferies Financial Group downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $103.00 to $95.00 in a report on Wednesday, July 24th. JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a report on Friday, October 11th. HSBC restated a “hold” rating on shares of Colgate-Palmolive in a report on Friday, July 26th. Finally, Barclays lifted their price target on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research note on Monday, July 29th. One research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $106.00.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.